Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-05-07
DOI
10.3389/fendo.2014.00061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1
- (2013) S. Sánchez-Tena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer
- (2013) Xiaoyong Fu et al. BREAST
- Cancer prevention by tocopherols and tea polyphenols
- (2013) Chung S. Yang et al. CANCER LETTERS
- Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
- (2013) N. Khan et al. CARCINOGENESIS
- Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
- (2013) Elena Lecumberri et al. CLINICAL NUTRITION
- Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor
- (2013) Emily J. Foulstone et al. ENDOCRINOLOGY
- Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2′-deoxycytidine (AZA) in breast cancer cells
- (2013) Li Zeng et al. EXPERIMENTAL CELL RESEARCH
- Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle Arrest
- (2013) Dong-Hu Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells
- (2013) Rita Castillo Cohen de Pace et al. JOURNAL OF LIPOSOME RESEARCH
- In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells
- (2013) Francesca De Amicis et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Green tea polyphenol, (−)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling
- (2013) Tripti Singh et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- The global breast cancer burden
- (2012) John R Benson et al. Future Oncology
- Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor
- (2011) Glenn S. Van Aller et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells
- (2011) S. M. Meeran et al. Cancer Prevention Research
- (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
- (2011) V. Nandakumar et al. CARCINOGENESIS
- Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
- (2011) Derliz Mereles et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFκB and AP-1 in the human breast cancer cell line MDA-MB-231
- (2010) Triparna Sen et al. ANTI-CANCER DRUGS
- Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
- (2010) Y. Li et al. CURRENT MEDICINAL CHEMISTRY
- Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer
- (2010) Imtiaz A. Siddiqui et al. FASEB JOURNAL
- Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells
- (2010) Yuanyuan Li et al. Molecular Cancer
- Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: Involvement of the insulin like growth factor-1 receptor
- (2010) Francis Thomas et al. PROSTATE
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
- (2008) Chih-Pin Chuu et al. CANCER LETTERS
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
- Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
- (2007) Joel B. Berletch et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now